Biohaven Pharmaceutical
North America, Connecticut, United States, New Haven
Description
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.
Investor Profile
Biohaven Pharmaceutical has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 67% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical, Pharmaceutical.
Stage Focus
- Series A (67%)
- Series B (33%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical
- Pharmaceutical
- Biopharma
- Biotechnology
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Biohaven Pharmaceutical frequently co-invest with?
What are some of recent deals done by Biohaven Pharmaceutical?
Find More Investors Like Biohaven Pharmaceutical
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
